Canada Markets closed

TerrAscend Corp. (TRSSF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.2800-0.0100 (-0.78%)
At close: 03:58PM EDT

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • F
    FP
    $CRLBF conversation
    Smartest mso analyst Pablo Zuanic says SAFE+ isn't dead. May even include 280E reform. November/December looks likely with Perlmutter retirement. He will go nuclear on the NDAA if forced. The man won't leave Congress without SAFE+. Seems like risk/reward now favors accumulators.
    $CRLBF $GTBIF $VRNOF $CURLF $TCNFF $CCHWF $TRSSF $MSOS $YOLO
  • L
    Lynn
    $AYRWF conversation
    $AAWH $VRNOF $GTBIF $CURLF $TCNNF $TRSSF $JUSHF $CRLBF $CNTMF

    Warren Buffet-Buy When Others Are Fearful
  • R
    Rahim
    from what I read. alot of people got fired in Michigan. and sales are down atleast 25%
  • G
    Gary
    Anybody know what was said at the fireside chat this afternoon?
  • S
    Steven
    Wow only 9 more -$.15 days to $0..what happened to this company....the future was so promising just sad..
  • F
    Flex
    4.92 million share transaction at end of day per TD Ameritrade
  • G
    Gary
    Nice run at the close. Maybe the hedge funds recognize the bottom and are buying what they can before safe banking or decrim
  • S
    Steven
    Rally Rally !!
  • F
    FP
    $CRLBF conversation
    Today I gave to: NORML, Marijuana Policy Project and The Bowl PAC. They are the opposite of SAM and those idiots. If you want INFLUENCE and CHANGE, now, 6-8 weeks before the 2022 elections is the time. Put your money where your money is!
    $CRLBF $GTBIF $VRNOF $CURLF $TCNNF $CCHWF $TRSSF $MSOS
  • M
    Matthew
    Man they sure sell a lot of product in NJ. Why’s this do beaten down?
  • s
    scoreggia
    They printed some good numbers! Just finished looking at their revs. Nothing wrong there! Wonder why or who is holding the price down?? Looks like this is the bottom. Im in
  • J
    JOHN
    GREAT REPORT........
    GAAP Net Income was $14.2 million as compared to net loss of $16 million in Q1 2022.
    see...!!!!
  • j
    jj
    $VRNOF conversation
    MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF
    And now …some good news:
    https://www.zerohedge.com/medical/hangover-free-weed-infused-beverages-becoming-all-rage
  • j
    jj
    $VRNOF conversation
    MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF
    As of this morning, there will be another ETF buyer of MSOs:
    https://finance.yahoo.com/news/etfmg-mj-cannabis-etf-multi-123800427.html
  • S
    Steven
    Can we hold this 10% bump at 2:30 for a 2 day "mini" rally ???
  • W
    William
    Added, glta
  • E
    Eric
    Furthermore, what was officially released was they hired a new President for NE operations. They have not made any sale leasebacks and they have the backing of a smart investor + operations guy, Jason Wild. If you are scared, sell out. I will be buying more stock as we go deeper, maybe sub 1 dollar on macro weakness.
  • m
    mica
    improved gross margin , improved ebitda and improved bottom line and 31% sals growth all from prior quarter and stock gets killed down 20% , Im truly at a loss for words, just when you think you have seen all the b-s over past 18 mths the OTC can give you then this ...just wow
  • j
    jj
    $VRNOF conversation
    MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF.
    Alan Brochstein commented on several MSOs in this week’s NCV edition:
    TRSSF, AYRWF, CCHWF, CRLBF, TLLTF & VRNOF
    “Ascend increased Q2 revenue by 15% sequentially and 17% year-over-year to $97.5 million, a record since the company’s inception. “The key driver of these results was the commencement of adult-use sales at our Rochelle Park, New Jersey dispensary, one of the top performing stores in the state,” said CEO and Co-founder Abner Kurtin. The company started adult-use sales at its Rochelle Park dispensary on April 21st, with store sales reaching as high as $1.25 million in a single week. Subsequent to quarter end, the company opened its Fort Lee, New Jersey dispensary for medical sales. It currently has 22 operating dispensaries.

    Ayr Wellness Q2 revenue inched down 1% sequentially to $110.1 million, but was up 21% from the same period a year ago. The company said the results were within expectations and it anticipates growth in the second half of the year to be slower. “We continue to make investments in people and processes, while remaining prudent through these turbulent economic times,” said Jonathan Sandelman, founder and CEO.

    Columbia Care Q2 revenue increased 5% sequentially to $129.6 million and was up 18% year-over-year from $109.7 million. The company said New Jersey, which recently launched adult use sales, was a primary driver in sequential revenue growth, along with Virginia and West Virginia, where Columbia Care is the number one wholesaler and retailer in rapidly expanding medical markets. “In these challenging times, Columbia Care achieved exceptional results in several key markets that serve as meaningful, positive long-term indicators. Despite the economic headwinds and challenges that were particularly impactful in our most mature markets, we saw surprising resilience across the country, in addition to outstanding performance in our highest growth, emerging markets,” said CEO Nicholas Vita.

    Cresco Labs increased Q2 revenue 2% sequentially to $218.2 million and was up 4% year-over-year. On July 8, Columbia Care shareholders approved a previously announced, all stock acquisition by Cresco Labs and the company anticipates it will close by year end. The company said over the next three years, growth will come from the transition to adult-use in seven large markets: New Jersey, New York, Pennsylvania, Ohio, Virginia, Florida and Maryland. “Our combined footprint with Columbia Care, gives us exposure to all of these markets and leading positions in several. This is arguably the highest value footprint in cannabis – 180 million Americans and all 10 of the 10 highest projected 2025 revenue states,” said CEO and Co-founder Charles Batchell.

    TILT Holdings increased Q2 revenue by 11% sequentially to $47.1 million and was down 3% from last year’s Q2 revenue of $48.5 million. The company said its cannabis operations grew more than 20% year-over-year. During the quarter, Tilt launched new products, announced new partnerships, and broke ground on a 5,000 square-foot cannabis dispensary located on Shinnecock tribal territory in Southampton, New York. “Early results have shown that we have the right strategy in place and the right team to execute upon it. That said, we are committed to increasing our pace given market conditions, with even more brand partners and SKUs to launch across a larger operating footprint going forward,” said CEO Gary Santo.

    Verano Q2 revenue was up 11% sequentially to $223.7 million and was up 12% from the previous year’s quarter. During the quarter, Verano launched adult-use sales in New Jersey and exceeded a milestone of operating more than 100 dispensariesfollowing the opening of seven new stores in Florida, West Virginia and Pennsylvania. It also announced a partnership with Mission Green to advance cannabis clemency and social equity initiatives, and launched mobile applications and rewards programs for its flagship Zen Leaf and MÜV dispensaries. “I am proud of what we have accomplished since going public last year and remain confident that the strategy and plans we have in place will drive long term, sustainable growth for Verano,” said founder and CEO George Archos.”
  • j
    jj
    $VRNOF conversation
    $MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF.
    25 days ago I posted the following:
    “IMO From a technical analysis basis ALL MSO stocks are in BUY status”
    As of Friday’s (8/5/22) close the entire MSO group is again in BUY status.
    I think that a solid short term bottom is in. The stocks are reacting positively to the news from the Feds, good news from GTBIF, bad news in a couple of cases has not cratered the group, e.g. GRWG bad earnings.
    announcement, even VRNOF it’s “restatement” is on the mend. I think the longs can breath a small sigh of relief as the selling pressure seems to be abating. The upcoming earning reports I think will be well received.